academic.oup.com
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Abstract. Obesity is now considered a chronic relapsing progressive disease, associated with increased all-cause mortality that scales with body weight, af
#Ozempic is an active hashtag on Bluesky. In the last 30 days, 59 people shared 82 posts with it — around 3 a day. Activity is up 41% versus the previous week, peaking on Aug 5 with 12 posts.
Tags most often used together with #Ozempic.
academic.oup.com
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Abstract. Obesity is now considered a chronic relapsing progressive disease, associated with increased all-cause mortality that scales with body weight, af
www.cell.com
Glucagon-like peptide-1 receptor
Michael Krashes discusses glucagon-like peptide-1 receptors, their physiological role in glucose metabolism and the mode of action of their agonists that are used to treat obesity and were later shown...
www.mediapart.fr
Obésité : ces médecins qui rusent pour soigner les moins aisés
Le médicament anti-obésité Wegovy de Novo Nordisk, hors de prix, n’est pas remboursé en France alors que la maladie touche davantage les populations précaires. Des médecins prescrivent son traitement…
newsmonkey.be
GLP-1-middelen zoals Ozempic gelinkt aan minder botbreuken
In het kort Recent onderzoek wijst erop dat GLP-1-medicijnen, waaronder Ozempic, de kans op ernstige botbreuken bij mensen met diabetes type 2 daadwerkelijk kunnen verminderen. Deze ontdekking spreekt eerdere aannames tegen dat het snelle gewichtsverlies dat met deze medicijnen gepaard gaat, per se de botintegriteit zou aantasten. Aanzienlijke daling van het aantal botbreuken Voor het […] The post GLP-1-middelen zoals Ozempic gelinkt aan minder botbreuken appeared first on Newsmonkey.
omniletters.com
Estudo analisa impacto do Ozempic na vida social e emocional
umlegacypressqsefc.com
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says: Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually. #BankOfAmerica #GLP1 #Ozempic #Wegovy #HealthCare
umlegacypressqsefc.com
Novo Nordisk’s raised forecast fails to change the debate over its obesity business: Wall Street isn’t convinced the Ozempic maker has a promising path back to sustainable growth as competition from Eli Lilly intensifies. #NovoNordisk #Ozempic #EliLilly #ObesityTreatment #Pharmaceuticals
www.ipharmacenter.com
Top 10 pharmaceutical companies by revenues in 2026 | Official Figures | iPharmaCenter
The first quarter of 2026 confirmed that GLP-1 drugs are still rewriting the global pharmaceutical revenue rankings. Eli Lilly posted $19.8 billion revenues, the fastest rate among the top 10 companie...
www.ipharmacenter.com
Top 10 pharmaceutical companies by revenues in 2026 | Official Figures | iPharmaCenter
The first quarter of 2026 confirmed that GLP-1 drugs are still rewriting the global pharmaceutical revenue rankings. Eli Lilly posted $19.8 billion revenues, the fastest rate among the top 10 companie...
www.ipharmacenter.com
Top 10 pharmaceutical companies by revenues in 2026 | Official Figures | iPharmaCenter
The first quarter of 2026 confirmed that GLP-1 drugs are still rewriting the global pharmaceutical revenue rankings. Eli Lilly posted $19.8 billion revenues, the fastest rate among the top 10 companie...
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.